Beta-Amyloid Peptides Publications
-
(2020)
Ikenoue, T., Aprile, F.A., Sormanni, P., et al.
A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease.
Scientific Reports; doi.org/10.1038/s41598-020-69626-3.
-
(2020)
Alghazwi, M., Charoensiddhi, S., Smide, S., Zhang, W.
Impact of Ecklonia radiata extracts on the neuroprotective activities against amyloid beta (Aβ1-42) toxicity and aggregation.
Journal of Functional Food; doi.org/10.1016/j.jff.2020.103893.
-
(2020)
Maina, M., Mengham, K., Burra, G., Al-Hilaly,Y., Serpell, L.
Dityrosine cross-link trapping of amyloid-β intermediates reveals that self-assembly is required for Aβ-induced cytotoxicity.
bioRxiv; www.biorxiv.org/content/10.1101/2020.03.25.007690v1.full.
-
(2020)
Wei, Z., Meng, X., Fatimy, R., Sun, B., Mai, D., Zhang, J., Arora, R., Zeng, A., Xu, P., Qu, S., Krichevsky, A., Selkoe, D., Li, S.,
Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways ..
Neurobiology of Disease; doi.org/10.1016/j.nbd.2019.104617.
-
(2020)
Kravenska,Y., Nieznanska,H., Nieznanski,K., Lukyanetz,E., Szewczyk,A., Koprowski,P.,
The monomers, oligomers, and fibrils of amyloid-β inhibit the activity of mitoBKCa channels by a membrane-mediated mechanism.
BBA; doi.org/10.1016/j.bbamem.2020.183337.
-
(2020)
Vermeire, P., Schepdael, A., Petersen, N.
Development of a novel sheathless CE-ESI-MS interface via a CO2 laser ablated opening.
Talanta; doi.org/10.1016/j.talanta.2020.120853.
-
(2020)
Henjum,K., Arskog,V., Jendresen,C.,Fladby,T., Torp,R., Nilsson,L.
Analyzing microglial-associated Aβ in Alzheimer’s disease transgenic mice with a novel mid-domain Aβ-antibody.
Scientific Reports; doi.org/10.1073/pnas.1700239114.
-
(2020)
Meyer, S., Schaeverbeke,J., Verbek, I., Gille, B., Schaepdryver, M., Luckett, E., Gabel, S., Bruffaerts, R., Mauroo, K., Thijssen, E., Stoops, E., Vanderstichele, H., Teunissen, C., Vandenberghe, R., Poesen, K.
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis.
Alzheimer’s Research & Therapy; doi.org/10.1186/s13195-020-00728-w.
-
(2020)
Al-Edresi, A., Alsalahat, I., Freeman, S., Aojula, H., Penny,J.
Resveratrol-mediated cleavage of amyloid β1-42 peptide; potential relevance to Alzheimer’s disease.
Neurobiology of Aging; doi.org/10.1016/j.neurobiolaging.2020.04.012.
-
(2020)
Natarajan, K., Ullgren, A., Khoshnood, B., Johansson, C., Laffita-Mesa, J., Pannee, J., Zetterberg, H., Blennow, K., Graff, C.
Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: A pilot study.
bioRxiv; doi: doi.org/10.1101/2020.05.16.093559..
